お申し込みはこちら 本セッションでは以下の内容を取り上げます:
ナビゲーションの効率化:ゲノム/遺伝子表示のアップデート、トランスクリプト選択機能の強化
高度なバリアント解釈ツール:スプライシング予測・ミスセンス予測、アノテーション機能のアップデート
効率的なデータ管理:アノテーションの作成・共有・インポート/エクスポートの簡素化
強化されたデータ表示機能:BAM、VCF、BED、サンガーシーケンスなど多様なデータ形式に対応
結果表示が調整可能なレポート機能:ラボのワークフローに合わせた結果出力の最適化
Alamut™ Visual Plus v2.0が高度なバリアント解析を支援し、ワークフローを最適化する方法をぜひご覧ください。皆様のご参加をお待ちしております!お申し込みはこちら

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.